Keywords: Apricis Biosciences, Topotarget, US subsidiary, Totect, Chemotherapy

Apricus Biosciences closes Topotarget USA acquisition

Article | 30 December 2011

Print This

Apricus Biosciences (Nasdaq: APRI) has closed its previously-announced acquisition of Topotarget USA, a subsidiary of Denmark’s Topotarget A/ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in